%0 Published Erratum
%T Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score.
%A Mainz JG
%A Zagoya C
%A Polte L
%A Naehrlich L
%A Sasse L
%A Eickmeier O
%A Smaczny C
%A Barucha A
%A Bechinger L
%A Duckstein F
%A Kurzidim L
%A Eschenhagen P
%A Caley L
%A Peckham D
%A Schwarz C
%J Front Pharmacol
%V 14
%N 0
%D 2023
%M 37205908
%F 5.988
%R 10.3389/fphar.2023.1207356
%X [This corrects the article DOI: 10.3389/fphar.2022.877118.].